Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

Similar articles for PubMed (Select 22733541)

1.

The zinc finger gene ZIC2 has features of an oncogene and its overexpression correlates strongly with the clinical course of epithelial ovarian cancer.

Marchini S, Poynor E, Barakat RR, Clivio L, Cinquini M, Fruscio R, Porcu L, Bussani C, D'Incalci M, Erba E, Romano M, Cattoretti G, Katsaros D, Koff A, Luzzatto L.

Clin Cancer Res. 2012 Aug 15;18(16):4313-24. Epub 2012 Jun 25.

2.

Comprehensive methylome analysis of ovarian tumors reveals hedgehog signaling pathway regulators as prognostic DNA methylation biomarkers.

Huang RL, Gu F, Kirma NB, Ruan J, Chen CL, Wang HC, Liao YP, Chang CC, Yu MH, Pilrose JM, Thompson IM, Huang HC, Huang TH, Lai HC, Nephew KP.

Epigenetics. 2013 Jun;8(6):624-34. doi: 10.4161/epi.24816. Epub 2013 May 10.

3.

LIM-homeobox transcription factor 1, alpha (LMX1A) inhibits tumourigenesis, epithelial-mesenchymal transition and stem-like properties of epithelial ovarian cancer.

Chao TK, Yo YT, Liao YP, Wang YC, Su PH, Huang TS, Lai HC.

Gynecol Oncol. 2013 Mar;128(3):475-82. doi: 10.1016/j.ygyno.2012.12.018. Epub 2012 Dec 24.

PMID:
23270808
4.

Identification of the chemokine CX3CL1 as a new regulator of malignant cell proliferation in epithelial ovarian cancer.

Gaudin F, Nasreddine S, Donnadieu AC, Emilie D, Combadière C, Prévot S, Machelon V, Balabanian K.

PLoS One. 2011;6(7):e21546. doi: 10.1371/journal.pone.0021546. Epub 2011 Jul 7.

5.

Tumor promoting properties of the ETS protein MEF in ovarian cancer.

Yao JJ, Liu Y, Lacorazza HD, Soslow RA, Scandura JM, Nimer SD, Hedvat CV.

Oncogene. 2007 Jun 7;26(27):4032-7. Epub 2007 Jan 8.

PMID:
17213815
6.

Zic2 synergistically enhances Hedgehog signalling through nuclear retention of Gli1 in cervical cancer cells.

Chan DW, Liu VW, Leung LY, Yao KM, Chan KK, Cheung AN, Ngan HY.

J Pathol. 2011 Dec;225(4):525-34. doi: 10.1002/path.2901. Epub 2011 Jun 10.

PMID:
21661123
7.

Death domain-associated protein DAXX promotes ovarian cancer development and chemoresistance.

Pan WW, Zhou JJ, Liu XM, Xu Y, Guo LJ, Yu C, Shi QH, Fan HY.

J Biol Chem. 2013 May 10;288(19):13620-30. doi: 10.1074/jbc.M112.446369. Epub 2013 Mar 28.

8.

CD164 regulates the tumorigenesis of ovarian surface epithelial cells through the SDF-1α/CXCR4 axis.

Huang AF, Chen MW, Huang SM, Kao CL, Lai HC, Chan JY.

Mol Cancer. 2013 Oct 5;12(1):115. doi: 10.1186/1476-4598-12-115.

9.
10.

Necdin, a p53-target gene, is an inhibitor of p53-mediated growth arrest.

Lafontaine J, Rodier F, Ouellet V, Mes-Masson AM.

PLoS One. 2012;7(2):e31916. doi: 10.1371/journal.pone.0031916. Epub 2012 Feb 15.

11.

Human kallikrein gene 11 (KLK11) mRNA overexpression is associated with poor prognosis in patients with epithelial ovarian cancer.

Shigemasa K, Gu L, Tanimoto H, O'Brien TJ, Ohama K.

Clin Cancer Res. 2004 Apr 15;10(8):2766-70.

12.

ETV5 transcription factor is overexpressed in ovarian cancer and regulates cell adhesion in ovarian cancer cells.

Llauradó M, Abal M, Castellví J, Cabrera S, Gil-Moreno A, Pérez-Benavente A, Colás E, Doll A, Dolcet X, Matias-Guiu X, Vazquez-Levin M, Reventós J, Ruiz A.

Int J Cancer. 2012 Apr 1;130(7):1532-43. doi: 10.1002/ijc.26148. Epub 2011 Aug 12.

PMID:
21520040
13.

High GOLPH3 expression is associated with a more aggressive behavior of epithelial ovarian carcinoma.

Ma Y, Ren Y, Zhang X, Lin L, Liu Y, Rong F, Wen W, Li F.

Virchows Arch. 2014 Apr;464(4):443-52. doi: 10.1007/s00428-014-1536-3. Epub 2014 Jan 24.

PMID:
24458516
15.

Transformation of epithelial ovarian cancer stemlike cells into mesenchymal lineage via EMT results in cellular heterogeneity and supports tumor engraftment.

Jiang H, Lin X, Liu Y, Gong W, Ma X, Yu Y, Xie Y, Sun X, Feng Y, Janzen V, Chen T.

Mol Med. 2012 Oct 24;18:1197-208. doi: 10.2119/molmed.2012.00075.

16.

Loss of ARID1A-associated protein expression is a frequent event in clear cell and endometrioid ovarian cancers.

Lowery WJ, Schildkraut JM, Akushevich L, Bentley R, Marks JR, Huntsman D, Berchuck A.

Int J Gynecol Cancer. 2012 Jan;22(1):9-14. doi: 10.1097/IGC.0b013e318231f140.

17.

An IL6-correlated signature in serous epithelial ovarian cancer associates with growth factor response.

Pinciroli P, Alberti C, Sensi M, Canevari S, Tomassetti A.

BMC Genomics. 2013 Jul 26;14:508. doi: 10.1186/1471-2164-14-508.

18.

VGLL3 expression is associated with a tumor suppressor phenotype in epithelial ovarian cancer.

Gambaro K, Quinn MC, Wojnarowicz PM, Arcand SL, de Ladurantaye M, Barrès V, Ripeau JS, Killary AM, Davis EC, Lavoie J, Provencher DM, Mes-Masson AM, Chevrette M, Tonin PN.

Mol Oncol. 2013 Jun;7(3):513-30. doi: 10.1016/j.molonc.2012.12.006. Epub 2013 Jan 16.

19.

The role of forkhead box Q1 transcription factor in ovarian epithelial carcinomas.

Gao M, Shih IeM, Wang TL.

Int J Mol Sci. 2012 Oct 26;13(11):13881-93. doi: 10.3390/ijms131113881.

20.

Modelling genetic and clinical heterogeneity in epithelial ovarian cancers.

Lawrenson K, Sproul D, Grun B, Notaridou M, Benjamin E, Jacobs IJ, Dafou D, Sims AH, Gayther SA.

Carcinogenesis. 2011 Oct;32(10):1540-9. doi: 10.1093/carcin/bgr140. Epub 2011 Aug 22.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk